ICICI Bank, Larsen & Toubro, Bharti Airtel, Mahindra & Mahindra, Eicher Motors, Maruti and SBI Life were among the blue-chip counters that pushed NSE Nifty to its all-time highs. The Indian markets touched a fresh high and also the closed firm. The current bull run in the Indian stocks has been one of the longest bull runs with very little room for any correction. Markets are seeming strongly positive at the moment. As we are currently in uncharted zone, we could see a further upside movement in the stocks. If there is a correction as this point, it could be very sharp and quick. However, there could be buying at lower levels which would mean that any correction would be short-lived. For the moment, no one is talking about correction. BSE Sensex closed the session with an impressive gain of 1360 points.

ICICI Bank share price was up by 4.4 percent with stock closing at Rs 1349 after touching an intraday high of Rs 1362. ICICI Bank opened the session at Rs 1295. Among automobile stocks, Mahindra & Mahindra was leading the pack with 5.32 percent gains for the day. The stock closed at Rs 2946.

Bharti Airtel share price jumped by 2.7 percent to close the session at Rs 1710.

The stocks which didn’t participate in today’s rally were Grasim, SBI, IndusInd Bank, Hero MotoCorp and IT major TCS.

Lemon Tree Hotels has announced a new property launch in Srinagar, expanding its footprint in India’s hospitality sector. Meanwhile, Tata Consultancy Services (TCS) is broadening its European presence with a new delivery center in Warsaw, aiming to double its workforce in Poland. EdTech company Physics Wallah has secured $210 million in Series B funding, doubling its valuation to $2.8 billion. Torrent Pharma received a regulatory observation from the US FDA after a recent inspection, while Samvardhana Motherson International completed an acquisition in REE Automotive. Mankind Pharma's shares hit a new high ahead of a board meeting to consider fundraising.

Lemon Tree Hotels Expands in Srinagar with New Property

New License Agreement with Subsidiary Carnation Hotels:
Lemon Tree Hotels announced a license agreement with its wholly-owned subsidiary, Carnation Hotels, to launch a new property, "Keys Select by Lemon Tree Hotels," in Srinagar, Jammu and Kashmir. The new 40-key property will further expand Lemon Tree’s presence in India’s hospitality market, targeting both leisure and business travelers in the scenic region.

Strategic Expansion in the Hospitality Sector:
This latest venture highlights Lemon Tree's ongoing strategy to broaden its portfolio across key tourist destinations. The company continues to leverage its subsidiary network to manage and operate new properties, driving growth and enhancing brand presence.

Tata Consultancy Services Expands Operations in Poland

New Delivery Centre in Warsaw and Workforce Expansion:
Tata Consultancy Services (TCS) announced the opening of a new delivery center in Warsaw, Poland, as part of its strategy to strengthen its European operations. TCS plans to double its workforce in the region to over 1,200 employees within a year. The new facility will showcase TCS’s diverse capabilities across industries and advanced technologies, underscoring its commitment to the European market.

Boosting Global Footprint in IT Services:
The expansion aligns with TCS's global growth strategy, enhancing its ability to deliver cutting-edge services to clients in Europe. The Warsaw center will serve as a critical hub for digital transformation services, catering to the evolving needs of businesses across the continent.

Physics Wallah Raises $210 Million in Series B Funding

Valuation More Than Doubles to $2.8 Billion:
Education technology company Physics Wallah (PW) has raised $210 million in a Series B funding round led by Hornbill Capital, Lightspeed Venture Partners, and existing investors GSV and WestBridge. The new funding brings PW’s post-money valuation to $2.8 billion, up from $1.1 billion in the previous round, reflecting strong investor confidence in the company’s growth potential.

Focus on Profitability and Expansion:
PW declared that FY25 will mark the group's "largest absolute profitability," signaling a robust financial outlook. The funds will be used to enhance its technology platform, expand its content library, and explore new market opportunities, further cementing its position as a leading player in the EdTech space.

Torrent Pharma Receives FDA Observation Following Inspection

Regulatory Scrutiny at Pithampur Manufacturing Facility:
Torrent Pharmaceuticals announced that it received one observation from the U.S. FDA following a Good Manufacturing Practices (GMP) inspection of its formulations manufacturing facility in Pithampur, Madhya Pradesh. The inspection, conducted between September 16 and 20, highlights the ongoing regulatory oversight faced by pharmaceutical manufacturers to ensure compliance with international quality standards.

Commitment to Address Regulatory Concerns:
Torrent Pharma stated it is working to address the FDA’s observation promptly. The company remains focused on maintaining high manufacturing standards and ensuring uninterrupted supply to its global markets.

Samvardhana Motherson International Completes Stake Acquisition in REE Automotive

Strategic Investment in Electric Vehicle Technology:
Samvardhana Motherson International announced the completion of its acquisition of an 11% stake in REE Automotive, marking a significant step in expanding its presence in the electric vehicle (EV) sector. This acquisition reflects Motherson’s strategic intent to diversify its portfolio and leverage growth opportunities in the evolving EV landscape.

Enhancing Capabilities in Next-Generation Mobility Solutions:
The investment in REE Automotive allows Motherson to strengthen its position in advanced automotive technologies, supporting its long-term vision of becoming a leading global supplier in the mobility sector.

Mankind Pharma Shares Surge Amid Fundraising Speculation

Stock Hits New High Amid Heavy Trading Volumes:
Shares of Mankind Pharma surged 7% to reach a new high of ₹2,596 on the BSE during Friday’s intra-day trade. The rally came amid heavy trading volumes ahead of the company’s board meeting to consider fundraising options, reflecting strong investor sentiment and expectations of future growth.

Positive Market Response to Strategic Developments:
The stock’s performance underscores market optimism about Mankind Pharma’s potential to raise capital for expansion initiatives. The company’s ability to navigate regulatory landscapes and maintain strong operational metrics continues to attract investor interest.